Feb 19 Analysis: Some natural supplements can be dangerously contaminated By C. Michael White, The Conversation Consumers take real risks if they use diet supplements not independently verified by reputable outside labs. Continue reading
Nov 15 U.S. approves new drug to manage sickle cell disease, costs $85,000 to $113,000 By Linda A. Johnson, Associated PRess The monthly infusion, which halves occurrences of sickle cell pain episodes, will carry a list price of roughly $85,000 to $113,000 per year, depending on dosing. Insured patients generally will pay less. Continue reading
Oct 08 Beauty products for vulvas? These doctors say don't buy it By Jamie Leventhal Instagram influencers and companies are selling cosmetic products for vulvas and "wellness" products for vaginas, which could put people at risk for infection and bacterial vaginosis. Continue reading
Sep 13 U.S. finds contaminant in popular heartburn drug By Matthew Perrone, Associated Press For now, the Food and Drug Administration said patients can continue taking Zantac and related generic drugs. Continue reading
Jul 24 Breast implant recalled after link to more rare cancer cases By Matthew Perrone, Associated Press The U.S. Food and Drug Administration said it called for the removal after new information showed Allergan's Biocell breast implants with a textured surface were tied to the vast majority of cases of a rare form of lymphoma. Continue reading
Jun 01 At first-ever public hearing on CBD, advocates and FDA try to blaze trail to regulatory compromise By Nicholas Florko, STAT The meeting on Friday was the public kickoff of the FDA’s quest to sketch a clear framework to regulate CBD, or cannabidiol, products. Continue reading
May 05 FDA to end program that hid millions of reports on faulty medical devices By Christina Jewett, Kaiser Health News In the wake of a Kaiser Health News investigation, the agency will no longer let device makers file reports of harm outside a widely used public database. Continue reading
Apr 16 U.S. halts sales of pelvic mesh tied to injuries in women By Matthew Perrone, Associated Press The Food and Drug Administration ordered the two remaining makers of the mesh to stop selling it immediately, saying the companies failed to show the mesh is safe for long-term use. The FDA action does not apply to surgical mesh… Continue reading
Apr 02 FDA says it's exploring CBD's uses. Does it work — and is it legal? By Carla K. Johnson, Candice Choi, Associated Press Products containing CBD are already in stores and sold online, so it's easy to believe there must be something special about the ingredient. But the claims are largely unproven and quality control standards don't exist. Continue reading
Mar 27 U.S. to require breast density information after mammograms By Matthew Perrone, Associated Press The Food and Drug Administration's proposed rules would standardize the information given to millions of women following scans to detect breast cancer. Continue reading